ATF6α activation in human and preclinical models of hepatocellular carcinoma is significantly associated with an aggressive tumour phenotype characterized by reduced survival, glycolytic reprogramming and local immunosuppression.
- Xin Li
- Cynthia Lebeaupin
- Mathias Heikenwälder